REFERENCES
1. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.
2. Liu YJ, Wang C. A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication. Cell Commun Signal. 2023;21:77.
3. Couch Y, Buzàs EI, Di Vizio D, et al. A brief history of nearly EV-erything - the rise and rise of extracellular vesicles. J Extracell Vesicles. 2021;10:e12144.
4. Coelho C, Brown L, Maryam M, et al. Listeria monocytogenes virulence factors, including listeriolysin O, are secreted in biologically active extracellular vesicles. J Biol Chem. 2019;294:1202-17.
5. Harrison NA, Gardner CL, da Silva DR, Gonzalez CF, Lorca GL. Identification of biomarkers for systemic distribution of nanovesicles from Lactobacillus johnsonii N6.2. Front Immunol. 2021;12:723433.
6. Guo M, Huang Y, Shi Y, et al. A review of exosome isolation based on membrane protein recognition: Methods, performance, and challenges. Anal Chim Acta. 2026;1410:345477.
7. Zhu L, Tian W, Yuan L, et al. Aptamer-based extracellular vesicle isolation, analysis and therapeutics. Interdiscip Med. 2023;1:e20220019.
8. Kohlberger M, Gadermaier G. SELEX: Critical factors and optimization strategies for successful aptamer selection. Biotechnol Appl Biochem. 2022;69:1771-92.
9. Stephens C, Goodey NM, Gubler U. A beginners guide to SELEX and DNA aptamers. Anal Biochem. 2025;703:115890.
10. Chen Z, Liu H, Jain A, Zhang L, Liu C, Cheng K. Discovery of aptamer ligands for hepatic stellate cells using SELEX. Theranostics. 2017;7:2982-95.
11. Chowdhury R, Eslami S, Pham CV, et al. Role of aptamer technology in extracellular vesicle biology and therapeutic applications. Nanoscale. 2024;16:11457-79.
12. Xie S, Sun W, Fu T, et al. Aptamer-based targeted delivery of functional nucleic acids. J Am Chem Soc. 2023;145:7677-91.
13. Alnaser-Almusa O, Mahmoud M, Ilyas M, et al. Recent advances in aptamer-based biosensing technology for isolation and detection of extracellular vesicles. Front Cell Dev Biol. 2025;13:1555687.
14. Slalmi A, Rabbah N, Battas I, Debbarh I, Medromi H, Abourriche A. Artificial intelligence-driven SELEX design of aptamer panels for urinary multi-biomarker detection in prostate cancer: a systematic and bibliometric review. Biomedicines. 2025;13:2877.
15. Ikemoto MJ, Kamikubo Y, Uta D, et al. Efficient and specific selection of high-affinity DNA aptamers targeting μ-opioid receptor via functional extracellular vesicles. Commun Biol. 2026;9:861.
16. Ströhle G, Gan J, Li H. Affinity-based isolation of extracellular vesicles and the effects on downstream molecular analysis. Anal Bioanal Chem. 2022;414:7051-67.
17. Sekhon SS, Kaur P, Kim Y, Sekhon SS. 2D graphene oxide-aptamer conjugate materials for cancer diagnosis. npj 2D Mater Appl. 2021;5:202.
18. Sun F, Jiang X, Shi J, et al. A protocol integrating aptamer based magnetic separation and gentle dsDNAse cleavage for exosomes isolation and multi-exosomics analysis. Anal Chim Acta. 2026;1382:344850.
19. Makkar S, Rana N, Priyadarshi N, Bajaj G, Kumar S, Singhal NK. Unravelling the therapeutic properties of aptamer-modified exosome nanocomposite. Adv Colloid Interface Sci. 2025;342:103517.
20. Song Z, Mao J, Barrero RA, Wang P, Zhang F, Wang T. Development of a CD63 aptamer for efficient cancer immunochemistry and immunoaffinity-based exosome isolation. Molecules. 2020;25:5585.
21. Yu J, Wei Y, Cui Z, Tian J, Cai H, Zhang W. Thermosensitive capturer coupled with the CD63 aptamer for highly efficient isolation of exosomes. ACS Macro Lett. 2024:Epub ahead of print.
22. Webber J, Stone TC, Katilius E, et al. Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscanTM) platform. Mol Cell Proteomics. 2014;13:1050-64.
23. Yin W, Chen H, Cai J, et al. Isolation of structurally heterogeneous TCR-CD3 extracellular vesicle subpopulations using caliper strategy. Angew Chem Int Ed Engl. 2023;62:e202300954.
24. Huang Y, Zhou F, Jia F, Yang N. Divalent aptamer-functionalized nanochannels for facile detection of cancer cell-derived exosomes. Sensors. 2023;23:9139.
25. Cha BS, Jang YJ, Lee ES, et al. Development of a novel DNA aptamer targeting colorectal cancer cell-derived small extracellular vesicles as a potential diagnostic and therapeutic agent. Adv Healthc Mater. 2023;12:e2300854.
26. Lee ES, Cha BS, Kim J, Reo SH, Son J, Park KS. Immobilization-free SELEX for aptamer discovery targeting colorectal cancer-derived small extracellular vesicles. J Nanobiotechnology. 2025;23:738.
27. Esposito CL, Quintavalle C, Ingenito F, et al. Identification of a novel RNA aptamer that selectively targets breast cancer exosomes. Mol Ther Nucleic Acids. 2021;23:982-94.
28. Zhao L, Yang G, Zhu C, et al. Three-step evolutionary enhanced capillary electrophoresis-SELEX for aptamer selection of exosome vesicles. Talanta. 2024;267:125203.
29. Kim J, Olsen TR, Zhu J, et al. Integrated microfluidic isolation of aptamers using electrophoretic oligonucleotide manipulation. Sci Rep. 2016;6:26139.
30. Liu B, Liu Y, Qiu L, et al. Deterministic evolution of aptamers via a microfluidic-integrated robotic platform using complex exosomes as targets. ACS Nano. 2026;20:5476-88.
31. Truong TT, Kaku Y, Bustos-Quevedo G, et al. Robotic centrifugal microfluidics with in-rotation liquid supply for the extraction of multiple liquid biopsy analytes in one platform. Biosensors. 2026;16:309.
32. Cui W, Xiao H, Wen X, et al. Identifying a cancer therapeutic target: cell-SELEX identifies a membrane protein for aptamer-mediated growth suppression. Proc Natl Acad Sci U S A. 2026;123:e2514681123.
33. Zhang Y, Zhang S, Ning Z, et al. Strategies for improving aptamer screening efficiency: library design, awareness innovation, and instrument assistance. Crit Rev Anal Chem. 2026;56:267-87.
34. He M, Wang Z, Wu X, et al. Functional SELEX and biomedical applications of aptamers: beyond molecular recognition. Angew Chem Int Ed Engl. 2025;64:e202424687.
35. Chen S, Zhang L, Yuan Q, Tan J. Current advances in aptamer-based biomolecular recognition and biological process regulation. Chem Res Chin Univ. 2022;38:847-55.
36. Citartan M, Kaur H, Presela R, Tang TH. Aptamers as the chaperones (Aptachaperones) of drugs-from siRNAs to DNA nanorobots. Int J Pharm. 2019;567:118483.
37. Hosseini Shamili F, Alibolandi M, Rafatpanah H, et al. Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score. J Control Release. 2019;299:149-64.
38. Gobbo J, Marcion G, Cordonnier M, et al. Restoring anticancer immune response by targeting tumor-derived exosomes with a HSP70 peptide aptamer. J Natl Cancer Inst. 2016;108:djv330.
39. Wang Q, Miao Z, Sun S, et al. Discovery of a novel DNA aptamer for impeding tumor metastasis by blocking the functional activity of target protein on exosome. Chem Eng J. 2025;522:167253.
40. Porciani D, Signore G, Marchetti L, Mereghetti P, Nifosì R, Beltram F. Two interconvertible folds modulate the activity of a DNA aptamer against transferrin receptor. Mol Ther Nucleic Acids. 2014;3:e144.
41. Jiang K, Kacherovsky N, Wang T, et al. Discovery and cryo-EM-guided development of a neuropilin-2-binding aptamer for receptor antagonism. J Am Chem Soc. 2026;148:21983-95.
42. Wu D, Yu Y, Jin D, Xiao MM, Zhang ZY, Zhang GJ. Dual-aptamer modified graphene field-effect transistor nanosensor for label-free and specific detection of hepatocellular carcinoma-derived microvesicles. Anal Chem. 2020;92:4006-15.
43. Pan L, Yuan C, Ma X, et al. DNA encoded multi-round profiling of extracellular vesicle membrane proteins for cancer diagnostics. Biosens Bioelectron. 2025;291:118055.
44. Cao H, Xu D, Su Y, et al. Evolution of aptamer materials maps exosomal surface proteins at the nano-bio interface. Nano Lett. 2026;26:4449-61.
45. Zheng H, Su N, Yan G, et al. Immunomagnetic capture and traceless release of native tumor-derived exosomes from human plasma for exploring interaction with recipient cells by aptamer-functionalized nanoflowers. Anal Chim Acta. 2024;1287:342109.
46. Chen Y, Gao D, Zhu Q, et al. Rapid exosome isolation and in situ multiplexed detection of exosomal surface proteins and microRNAs on microfluidic platform. Analyst. 2023;148:2387-94.
47. Wang G, Pan Z, Zhu X, et al. Mesoporous magnetic nanoparticles conjugated aptamers for exosomes capture and detection of Alzheimer’s disease. Eng Regen. 2023;4:349-56.
48. Su N, Zhang J, Liu W, et al. Specific isolation and quantification of PD-L1 positive tumor derived exosomes for accurate breast cancer discrimination via aptamer-functionalized magnetic composites and SERS immunoassay. Talanta. 2025;281:126956.
49. Huang W, Yu Y, Yang C, et al. Aptamer decorated magnetic graphene oxide nanoparticles for effective capture of exosomes. Chem Eng J. 2022;431:133849.
50. Haizan I, Choi MY, Park DH, Choi JH. Dual-target magneto-immunoassay with bifunctional nanohybrids for breast cancer exosome detection. Talanta. 2025;286:127532.
51. Liu Y, Liu H, Xie Q, et al. Ag@MNPs-based electrochemical and colorimetric dual-modal strategy for facile multiplex analysis of exosomes. Sens Actuators B Chem. 2025;429:137287.
52. Sun D, Wang H, Li W, et al. Electrochemical detection of cancer cell-derived small extracellular vesicles based on three aptamer recognition and dual signal amplification. Sens Actuators B Chem. 2025;442:138096.
53. Miller L, Goodrum R, Ströhle G, Li H. Comparison of extracellular vesicle elution methods from aptamer-conjugated magnetic beads for downstream physical characterization and immunoassays. Can J Chem. 2025.
54. Miller L, Misra M, Li H. Methods for eluting intact extracellular vesicles from aptamer-based affinity chromatography: a critical evaluation based on downstream applications. Biotechnol J. 2025;20:e202400648.
55. Cong XZ, Feng J, Zhang HJ, et al. Microfluidic device-based in vivo detection of PD-L1-positive small extracellular vesicles and its application for tumor monitoring. Anal Chem. 2024;96:2658-65.
56. Zhou Z, Chen Y, Qian X. Target-specific exosome isolation through aptamer-based microfluidics. Biosensors. 2022;12:257.
57. Meng Y, Zhang Y, Bühler M, et al. Direct isolation of small extracellular vesicles from human blood using viscoelastic microfluidics. Sci Adv. 2023;9:eadi5296.
58. Xi X, Yi K, Xu L, et al. 3D dynamic magnetic microfluidic chip for efficient plasma extracellular vesicle enrichment and machine learning-based multiparametric diagnosis of hepatocellular carcinoma. J Nanobiotechnology. 2025;24:8.
59. Meggiolaro A, Moccia V, Brun P, et al. Microfluidic strategies for extracellular vesicle isolation: towards clinical applications. Biosensors. 2022;13:50.
60. Wang C, Zhang D, Yang H, et al. A light-activated magnetic bead strategy utilized in spatio-temporal controllable exosomes isolation. Front Bioeng Biotechnol. 2022;10:1006374.
61. Tang J, Jia X, Li Q, et al. A DNA-based hydrogel for exosome separation and biomedical applications. Proc Natl Acad Sci U S A. 2023;120:e2303822120.
62. Luo J, Wang B, Tang X, et al. CRISPR/Cas12a-loaded intelligent DNA hydrogel for universal and ultrasensitive exosome assay. VIEW. 2024;5:20230086.
63. Jiang Z, Luo K, Yang G, et al. An electrochemiluminescent sensor based on glycosyl imprinting and aptamer for the detection of cancer-related extracellular vesicles. Anal Chem. 2024;96:2550-8.
64. Feng D, Ren M, Miao Y, et al. Dual selective sensor for exosomes in serum using magnetic imprinted polymer isolation sandwiched with aptamer/graphene oxide based FRET fluorescent ignition. Biosens Bioelectron. 2022;207:114112.
65. Zhu H, Chen X, Liu W, et al. CLCtips: an integrated pipette-tip platform for high-efficiency extracellular vesicle proteomics via aptamer-mediated capture and on-tip digestion. Anal Chem. 2026;98:6896-906.
66. Wang L, Liang Y, Sulaiman M, et al. A bioinspired three-dimensional high-curvature nano-interface integrated microfluidic chip for small extracellular vesicles enrichment and machine learning-assisted prostate cancer precision diagnosis. Adv Sci. 2026;13:e21178.
67. Lu Y, Lin B, Liu W, et al. Isolation of PD-L1 extracellular vesicle subpopulations using DNA computation mediated microfluidic tandem separation. Small Methods. 2023;7:e2300516.
68. Woo HK, Kim C, Choi Y, et al. Automated disc device for multiplexed extracellular vesicle isolation and labelling from liquid biopsies in cancer diagnostics. Nat Biomed Eng. 2026;10:882-96.
69. Xiong Y, He L, Yang M, et al. Proximity hybridization-mediated fluorescence resonance energy transfer for highly specific detection of tumor-derived exosomes: Combining multiple exosomal surface markers. Sens Actuators B Chem. 2022;353:131126.
70. Park J, Lee SH, Cha B, Kim W, Park J. Multiplexed immuno-acoustic separation of exosome and lipoprotein from platelet using acoustic radiation force. Sens Actuators B Chem. 2026;454:139580.
71. Ding Z, Wei Y, Han F, Zhang X, Xu Z. DNA-driven photothermal amplification transducer for highly sensitive visual determination of extracellular vesicles. ACS Sens. 2023;8:2282-9.
72. Wang D, Xi B, Liang Y, et al. Thermodynamic-kinetic tailored photothermal-responsive molecular switching for extracellular vesicle manipulation. ACS Nano. 2026;20:18919-33.
73. Ren Y, Ge K, Lu W, et al. Multivalent DNA flowers for high-performance isolation, detection, and release of tumor-derived extracellular vesicles. ACS Appl Mater Interfaces. 2023;15:55358-68.
74. Wang Y, Zhang H. Gold nanoparticles engineered nanoporous membrane with sandwich structure for sensitive electrochemical quantification of exosome. Sens Actuators B Chem. 2023;393:134294.
75. Zhao X, Zhang W, Qiu X, Mei Q, Luo Y, Fu W. Rapid and sensitive exosome detection with CRISPR/Cas12a. Anal Bioanal Chem. 2020;412:601-9.
76. Yuan R, Cai J, Ma H, Luo Y, Wang L, Su S. Recent progress in electrochemical aptasensors: construction and application. Chemosensors. 2023;11:488.
77. Aljohani MA. Exosomes in clinical laboratory: from biomarker discovery to diagnostic implementation. Medicina. 2025;61:1930.
78. Cui Y, Chen Y, Zhang Y, Zhang L. Advances in aptamer technology for target-based drug discovery. J Pharm Anal. 2026;16:101369.
79. Zheng L, Li J, Li Y, et al. Empowering exosomes with aptamers for precision theranostics. Small Methods. 2025;9:e2400551.
80. Xu R, Tang Q, Ying Y, Han D. Surface functionalization of extracellular vesicles with nucleic acids towards biomedical applications. Curr Top Med Chem. 2023;23:1307-18.
81. Dzarieva FM, Pavlova SA, Pavlova GV, Fab LV. Aptamers and endocytosis: the path into tumor cells. Biochem Biophys Res Commun. 2025;791:152960.
82. Hosseini NF, Amini R, Ramezani M, Saidijam M, Hashemi SM, Najafi R. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer. Biomed Pharmacother. 2022;155:113690.
83. Mettlen M, Chen PH, Srinivasan S, Danuser G, Schmid SL. Regulation of clathrin-mediated endocytosis. Annu Rev Biochem. 2018;87:871-96.
84. Kelly BT, Owen DJ. Endocytic sorting of transmembrane protein cargo. Curr Opin Cell Biol. 2011;23:404-12.
85. Pishavar E, Yazdian-Robati R, Abnous K, et al. Aptamer-functionalized mesenchymal stem cells-derived exosomes for targeted delivery of SN38 to colon cancer cells. Iran J Basic Med Sci. 2023;26:388-94.
86. Wang J, Li S, Luo T, Wang C, Zhao J. Disulfide linkage: a potent strategy in tumor-targeting drug discovery. Curr Med Chem. 2012;19:2976-83.
87. Ma W, Wang X, Zhang D, Mu X. Research progress of disulfide bond based tumor microenvironment targeted drug delivery system. Int J Nanomedicine. 2024;19:7547-66.
88. Erdogan O, Melike Demirbolat G, Cevik O. Raloxifene-loaded and aptamer-bonded exosomes induce autophagic and apoptotic death in HeLa cells by enhancing the lysosomotropic effect. BIOCELL. 2023;47:1051-63.
89. Chahal GS, Helbig KJ, Parton RG, Monson EA. The biology of endosomal escape: strategies for enhanced delivery of therapeutics. ACS Nano. 2026;20:1789-813.
90. Kim J, Hwang YH, Nam GH, Kim IS. Breaking barriers: engineering extracellular vesicles for enhanced endosomal escape and therapeutic delivery. J Control Release. 2026;389:114462.
91. Desai N, Rana D, Salave S, Benival D, Khunt D, Prajapati BG. Achieving endo/lysosomal escape using smart nanosystems for efficient cellular delivery. Molecules. 2024;29:3131.
92. Paillard A, Hindré F, Vignes-Colombeix C, Benoit JP, Garcion E. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials. 2010;31:7542-54.
93. Bahreyni A, Mohamud Y, Ashraf Nouhegar S, Zhang J, Luo H. Synergistic viro-chemoimmunotherapy in breast cancer enabled by bioengineered immunostimulatory exosomes and dual-targeted coxsackievirus B3. ACS Nano. 2024;18:4241-55.
94. Uddin N, Binzel DW, Shu D, Fu TM, Guo P. Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome. Acta Pharm Sin B. 2023;13:1383-99.
95. Zhou Q, Fang L, Tang Y, et al. Exosome-mediated delivery of artificial circular RNAs for gene therapy of bladder cancer. J Cancer. 2024;15:1770-8.
96. Liu X, Zhang G, Yu T, et al. CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy. Int J Biol Macromol. 2023;250:126147.
97. Yang Z, Ji P, Li Z, et al. Improved extracellular vesicle-based mRNA delivery for familial hypercholesterolemia treatment. Theranostics. 2023;13:3467-79.
98. Fu S, Tian Z, Liu L, et al. GelMA hydrogel loading circNEFM-engineered exosomes inhibits glioma growth. ACS Biomater Sci Eng. 2025;11:6671-83.
99. Shi X, Zhao Y, Tang Y, et al. In vitro transcribed circRNA as a therapeutic agent for cancer. Acta Pharm Sin B. 2026;16:4285-313.
100. Elsharkasy OM, Hegeman CV, Driedonks TAP, et al. A modular strategy for extracellular vesicle-mediated CRISPR-Cas9 delivery through aptamer-based loading and UV-activated cargo release. Nat Commun. 2025;16:10309.
101. Hegeman CV, Elsharkasy OM, Driedonks TAP, Friesen KRJ, Vader P, de Jong OG. Modulating binding affinity of aptamer-based loading constructs enhances extracellular vesicle-mediated CRISPR/Cas9 delivery. J Control Release. 2025;384:113853.
102. Xu JZ, An Y, Sun JX, et al. Oncolytic virus OH2 induces PD-L1 upregulation via NF-κB signaling and synergizes with anti-PD-L1 therapy in prostate cancer through a targeted extracellular vesicle delivery system. J Immunother Cancer. 2026;14:e013818.
103. Zhuang J, Tan J, Wu C, et al. Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy. Nucleic Acids Res. 2020;48:8870-82.
104. Zhang C, Tang S, Wang M, et al. “Triple-Punch” strategy exosome-mimetic nanovesicles for triple negative breast cancer therapy. ACS Nano. 2024;18:5470-82.
105. Quintavalle C, Ingenito F, Roscigno G, et al. Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1. Cell Death Discov. 2025;11:94.
106. Luo ZW, Li FX, Liu YW, et al. Aptamer-functionalized exosomes from bone marrow stromal cells target bone to promote bone regeneration. Nanoscale. 2019;11:20884-92.
107. Sun JG, Gao Y, Gao YS, Dai XJ, Chen P. Identification of the exosomal PD-L1 inhibitor to promote the PD-1 targeting therapy of gastric cancer. Eur J Med Chem. 2024;268:116182.
108. Yadav P, Preedia BE, Viegas N, et al. Bacterial exosomes cargo vaccine with EpCAM aptamers for targeting hepatocellular carcinoma. J Hepatol. 2023;78:S556-7.
109. Tu Z, Lin J, Li Z, et al. Tackling allergic airway inflammation with organic sheet-like nanoplatforms by targeted elimination of epithelial small extracellular vesicles. Adv Sci. 2025;12:e04197.
110. Basak M, Chaudhary DK, Takahashi RU, et al. Immunocyte derived exosomes: insight into the potential chemo-immunotherapeutic nanocarrier targeting the tumor microenvironment. ACS Biomater Sci Eng. 2023;9:20-39.
111. Wu Q, Wu Q, Lin H, et al. Microfluidic replication and phenotypic profiling of extracellular vesicles from the tumor microenvironment using dual-switch aptamer logic gates. Anal Chem. 2025;97:5313-23.
112. Su Y, Gao Q, Deng R, et al. Aptamer engineering exosomes loaded on biomimetic periosteum to promote angiogenesis and bone regeneration by targeting injured nerves via JNK3 MAPK pathway. Mater Today Bio. 2022;16:100434.
113. Jeong E, Choi JH, Lee M, et al. Aptamer-engineered ellipsometry for clinical detection of BALF-derived exosomes: multi-level engineering for prognostic evaluation of immunotherapy responses. Adv Sci. 2026;13:e15247.
114. Hao J, Wang J, Dong Y, et al. Homogeneous, simple, and direct analysis of exosomal PD-L1 via aptamer-bivalent-cholesterol-anchor assembly of DNAzyme (ABCzyme) for tumor immunotherapy. Anal Chem. 2023;95:6854-62.
115. Muhammad M, Shao C, Liu C, Song G, Zhan J, Huang Q. Monitoring of circulating exosomal immuno checkpoint in tumor microenvironment through ultrasensitive aptamer-functionalized SERS probes. Biosens Bioelectron X. 2022;12:100177.
116. Zhang YP, Chen HJ, Hu Y, et al. Accurate cancer screening and prediction of PD-L1-guided immunotherapy efficacy using quantum dot nanosphere self-assembly and machine learning. Nano Lett. 2024;24:1816-24.
117. Li Y, Li Y, Ying M, et al. Ultrasensitive profiling of extracellular vesicles by a microbead- and aptamer-enhanced thermophoretic assay for monitoring therapeutic responses. Anal Chem. 2025;97:26960-70.
118. Ren X, Zhao Y, Xue F, et al. Exosomal DNA aptamer targeting α-synuclein aggregates reduced neuropathological deficits in a mouse Parkinson’s disease model. Mol Ther Nucleic Acids. 2019;17:726-40.
119. Du B, Zou Q, Wang X, et al. Multi-targeted engineered hybrid exosomes as Aβ nanoscavengers and inflammatory modulators for multi-pathway intervention in Alzheimer’s disease. Biomaterials. 2025;322:123403.
120. Zhang C, You J, Lin R, et al. Engineering self-assembled PEEK scaffolds with marine-derived exosomes and bacteria-targeting aptamers for enhanced antibacterial functions. J Funct Biomater. 2025;17:23.
121. Cui F, Song Y, Ji H, et al. GlycoEVLR: glycosylated extracellular vesicle-like receptors for targeting and sensing viral antigen. Chem Eng J. 2023;469:143844.
122. Chen Y, Yang Y, Yang S, et al. A universal bio-hybrid nanoparticle backpack platform endows stem cells with microenvironmental resilience and sustained paracrine signaling. Nanomicro Lett. 2026;18:441.
123. Liu B, Li D. Structural transformation induced by locked nucleic acid or 2’-O-methyl nucleic acid site-specific modifications on thrombin binding aptamer. Chem Cent J. 2014;8:19.
124. Rajendran RL, Gangadaran P, Ghosh S, Nagarajan AK, Batabyal R, Ahn BC. Unlocking the secrets of single extracellular vesicles by cutting-edge technologies. Pathol Res Pract. 2025;269:155878.
125. Lötvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913.
126. Welsh JA, Goberdhan DCI, O’Driscoll L, et al.; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.
127. Zhang X, Jia Y, Li Z, et al. Microfluidic biochip-based multiplexed profiling of small extracellular vesicles proteins integrated with machine learning for early disease diagnosis. Adv Sci. 2025;12:e06167.
